The Business Development and Commercial Strategy team at Cardiol Therapeutics is responsible for identifying and pursuing strategic partnerships, licensing opportunities, and market entry strategies to accelerate the commercialization of anti-inflammatory therapies for cardiovascular disease. This team collaborates closely with research and clinical teams to align product development with market demands and formulates strategies to enhance the company's competitive position within the biotechnology landscape.
View all